Among the functionally enriched terms in the KEGG and Reactome pathways we could find PI3K/Akt, MAPK, HIF-1, mTOR, VEGF and EGFR inhibitor resistant pathways, all of which are well established as involved in CRC development. The gene discussed is HIF1A; the disease is colorectal carcinoma.